I created a woman's virgin and that's what I learned.

This is the second time she has been in charge of the company responsible for the development of a shepherd who aims to deal with a hippoactive sexual desire disorder in premenopausian women.

The US Food and Drug Administration, late last year after two previous failures, has approved this drug, Kosovo Prees broadcasts.

Eckert sold the Sprout Company for a billion-dollar Vallent company in August 2015. And then things fell to ruin. The retail company Cirtro Research compared Vallent to Enron, a company that has become known for its bankruptcy due to a series of financial frauds and corruption.

After Vallent's fall, the sale of grass was not so successful. Many security homes refused to cover grass expenses, and Addy received much criticism because of the high price and low level of influence.

In March of this year, Eckert and the group of Spout shareholders filed charges against Vallent, saying the bar price is high and that its commercialisation has failed.

It's not true that the sale started. The theoretical grass was in the chain of supply, but the opportunity for women to get it was direct”, said Eckert.

In November, Vallent gave up and handed it to Spout to his ex-owners free of charge. An agreement was reached for shareholders to give up the indictment, and Vallent would give them six percent of Addy's global sales for compensation. Valeant agreed to extend $25m to the company to finance the costs of starting business”.

So Eckert again sat in the principal's chair and began to make some drastic changes in order to increase sales. She released the bar price from 800 to $400 per monthly dose. Women will pay an average of $25 if their insurance covers expenses and those who do not cover insurance costs will not pay more than $99.

“I need to regulate access to the bar to ensure that women get accurate information. My prices will be similar to those of drugs PDE5 for men, including Viagra and Cialis, where the 80 percent price is covered by security”, she said.

Eckert plans to launch a new website and expand the market. Addy has already received approval for sale to Canada, where he is expected to officially start selling at the end of this year.

For the past two years, this entrepreneur has become an investor thanks to her new Pink Cheiling venture, which is something between the incubator and the consulting firm. She invests in women-run companies and focuses on solving health problems. Her motto is very simple.

I want other women to be rich. I strongly believe that when women have money, they have the freedom to make decisions and invest in things that matter to”, she said.

It has invested about $15m in 10 different health tablets so far.

My book will be called 0101. I've got Sprout for nothing, I've sold him a billion, I've turned for nothing, and from this, I hope I'm going to create a billion dollars worth of fortune for other women”, she said.